重庆医学2025，Vol.54Issue(7)：1571-1575,1580,6.DOI:10.3969/j.issn.1671-8348.2025.07.008
超微血管成像在卵巢癌分期预测中的价值研究
Study on the value of superb microvascular imaging in prediction of ovarian cancer staging
摘要
Abstract
Objective To evaluate the application value of superb microvascular imaging(SMI)in pre-dicting ovarian cancer staging.Methods One hundred and thirty-six patients with ovarian cancer who under-went surgical treatment in our hospital from March 2019 to May 2024 were enrolled.Transvaginal,transab-dominal low-frequency,and transabdominal high-frequency two-dimensional grayscale imaging,Color Doppler Flow Imaging(CDFI),and SMI were performed before surgery for staging prediction.Taking surgical-patho-logical staging as the gold standard,the sensitivity,specificity,and accuracy of the combined application of transvaginal SMI,transabdominal low-frequency SMI,and transabdominal high-frequency SMI for predicting ovarian cancer staging were calculated.The receiver operating characteristic(ROC)curve was established,the area under the ROC curve(AUC)was calculated,and the diagnostic efficacy of SMI for predicting ovarian cancer staging was determined.Results The combined application of transvaginal SMI,transabdominal low-frequency SMI,and transabdominal high-frequency SMI for predicting ovarian cancer staging showed that sen-sitivity was 89.35%,92.36%,81.65%,and 83.21%for stages Ⅰ,Ⅱ,Ⅲ,Ⅳ,respectively;specificity was 86.93%,84.29%,83.39%,and 82.88%;accuracy was 92.50%,94.38%,80.15%,and 84.96%;and AUC was 0.799,0.760,0.695,and 0.727.Conclusion SMI has a high application value in predicting the stage of ovarian cancer,especially for stage Ⅰ and stage Ⅱ ovarian cancer.关键词
超微血管成像/卵巢癌/分期/彩色多普勒血流显像Key words
superb microvascular imaging/ovarian cancer/staging/CDFI分类
医药卫生引用本文复制引用
谢敏,王惠,丁晓亚,崔丽清,钟毓,邹海蓉,曹熠熠..超微血管成像在卵巢癌分期预测中的价值研究[J].重庆医学,2025,54(7):1571-1575,1580,6.基金项目
重庆市卫生健康委员会医学科研项目(2024WSJK060). （2024WSJK060）
